Qiliqiangxin regulates the balance between tumor necrosis factor-α and interleukin-10 and improves cardiac function in rats with myocardial infarction

被引:82
作者
Xiao, Hong [1 ,2 ]
Song, You [1 ]
Li, Ya [1 ]
Liao, Yu-hua [1 ]
Chen, Jian [1 ]
机构
[1] Huazhong Univ Sci & Technol, Lab Cardiovasc Immunol, Inst Cardiol, Union Hosp,Tongji Med Coll, Wuhan 430022, Peoples R China
[2] NO1 Hosp Wuhan, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
Qiliqiangxin; Myocardial infarction; Cytokine; Tumor necrosis factor-alpha; Interleukin-10; HEART-FAILURE; INFLAMMATION; HERB;
D O I
10.1016/j.cellimm.2009.09.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The study investigated the effects of traditional Chinese drug Qiliqiangxin on cardiac function and the expression of pro/anti-inflammatory cytokines TNF-alpha/IL-10 in rats with myocardial infarction (MI). Rats with MI were randomly divided into drug-treated group (MI-Q) and control group (MI-C) compared with sham-operated group (S). Rats in the MI-Q group were treated with crude drug of oral Qiliqiangxin 24 h after operation at the dosage of 4 g/kg/day for 4 weeks, while in MI-C group and S group were treated with normal saline at the same time. Echocardiography and hemodynamic parameters, histopathologic changes and the expression of myocardial cytokines including TNF-alpha and IL-10 were assessed 4 weeks after the drug therapy. The results indicated that rats of the MI-C group exhibited decreased cardiac function and increased ratio of TNF-alpha/IL-10 which principally secreted by myocardium compared with those of the S group and Qiliqiangxin treatment significantly improved cardiac function and histopathologic changes with down-regulated ratio of TNF-alpha/IL-10. These data suggests that Qiliqiangxin may improve cardiac function of rats with MI through regulation the balance between TNF-alpha and IL-10. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 20 条
[1]   Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina -: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes [J].
Aukrust, P ;
Müller, F ;
Ueland, T ;
Berget, T ;
Aaser, E ;
Brunsvig, A ;
Solum, NO ;
Forfang, K ;
Froland, SS ;
Gullestad, L .
CIRCULATION, 1999, 100 (06) :614-620
[2]   Th1/Th2 functional imbalance after acute myocardial infarction: Coronary arterial inflammation or myocardial inflammation [J].
Cheng, X ;
Liao, YH ;
Ge, HX ;
Li, B ;
Zhang, JY ;
Yuan, J ;
Wang, M ;
Liu, Y ;
Guo, ZQ ;
Chen, J ;
Zhang, J ;
Zhang, LJ .
JOURNAL OF CLINICAL IMMUNOLOGY, 2005, 25 (03) :246-253
[3]   Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial [J].
Chung, ES ;
Packer, M ;
Lo, KH ;
Fasanmade, AA ;
Willerson, JT .
CIRCULATION, 2003, 107 (25) :3133-3140
[4]   Inflammatory mediators and the failing heart: A translational approach [J].
Diwan, A ;
Tran, T ;
Misra, A ;
Mann, DL .
CURRENT MOLECULAR MEDICINE, 2003, 3 (02) :161-182
[5]  
Gullestad L, 2001, Heart Fail Monit, V2, P8
[6]   Significance of changes in TNF-α and IL-10 levels in the progression of heart failure subsequent to myocardial infarction [J].
Kaur, K. ;
Sharma, A. K. ;
Singal, P. K. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (01) :H106-H113
[7]   Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction [J].
Li, Bin ;
Liao, Yu-Hua ;
Cheng, Xiang ;
Ge, Hongxia ;
Guo, Heping ;
Wang, Min .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 111 (02) :247-255
[8]  
Lin JS, 2007, EXP BIOL MED, V232, P557
[9]  
Ling JH, 2008, CHINESE J DIFFICULT, V5, P49
[10]   The role of inflammation in the pathogenesis of heart failure [J].
Lisman K.A. ;
Stetson S.J. ;
Koerner M.M. ;
Farmer J.A. ;
Torre-Amione G. .
Current Cardiology Reports, 2002, 4 (3) :200-205